MC2025A1 - Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee - Google Patents
Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controleeInfo
- Publication number
- MC2025A1 MC2025A1 MC892044A MC2044A MC2025A1 MC 2025 A1 MC2025 A1 MC 2025A1 MC 892044 A MC892044 A MC 892044A MC 2044 A MC2044 A MC 2044A MC 2025 A1 MC2025 A1 MC 2025A1
- Authority
- MC
- Monaco
- Prior art keywords
- azelastine
- active substance
- release
- substances
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Switches With Compound Operations (AREA)
- Polyurethanes Or Polyureas (AREA)
- Rotary Pumps (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3813244 | 1988-04-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MC2025A1 true MC2025A1 (fr) | 1990-04-25 |
Family
ID=6352451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MC892044A MC2025A1 (fr) | 1988-04-20 | 1989-04-11 | Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0338444B1 (pt) |
| JP (1) | JP2950845B2 (pt) |
| AT (1) | ATE97572T1 (pt) |
| AU (1) | AU3318389A (pt) |
| CA (1) | CA1325976C (pt) |
| DE (1) | DE58906232D1 (pt) |
| DK (1) | DK172235B1 (pt) |
| ES (1) | ES2060685T3 (pt) |
| FI (1) | FI891865A7 (pt) |
| HK (1) | HK134494A (pt) |
| HU (1) | HU202403B (pt) |
| IE (1) | IE62778B1 (pt) |
| MC (1) | MC2025A1 (pt) |
| PT (1) | PT90308B (pt) |
| ZA (1) | ZA892877B (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9003903D0 (sv) * | 1990-12-07 | 1990-12-07 | Astra Ab | New pharmaceutical formulations |
| DE4207234A1 (de) * | 1992-03-07 | 1993-09-09 | Asta Medica Ag | Neue aminocarbonsaeure-derivate mit antiallergischer/antiasthmatischer wirkung und verfahren zu deren herstellung |
| JPH0710747A (ja) * | 1993-04-28 | 1995-01-13 | Takeda Chem Ind Ltd | 固形製剤およびその製造方法 |
| GB9514842D0 (en) * | 1995-07-20 | 1995-09-20 | Smithkline Beecham Plc | Novel formulation |
| JP4138910B2 (ja) | 1997-07-02 | 2008-08-27 | 帝國製薬株式会社 | 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤 |
| UA67802C2 (uk) * | 1998-10-23 | 2004-07-15 | Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. | Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції |
| HU230454B1 (hu) | 1998-11-02 | 2016-07-28 | Alkermes Pharma Ireland Limited | Metilfenidátot tartalmazó módosított felszabadulású sokszemcsés készítmény |
| US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
| WO2001032148A1 (en) | 1999-10-29 | 2001-05-10 | Euro-Celtique, S.A. | Controlled release hydrocodone formulations |
| CN101317825A (zh) | 2000-10-30 | 2008-12-10 | 欧罗赛铁克股份有限公司 | 控释氢可酮制剂 |
| EP1396263A1 (en) * | 2002-08-09 | 2004-03-10 | Warner-Lambert Company | Film coating for tablets and caplets |
| JP2006523613A (ja) * | 2002-12-20 | 2006-10-19 | エスティ.ジェイムス アソシエイト エルエルシー/フェイバー リサーチ シリーズ | 徐放性医薬投与のための被覆粒子 |
| PL2486942T3 (pl) * | 2004-11-24 | 2019-05-31 | Meda Pharmaceuticals Inc | Kompozycje zawierające azelastynę oraz sposoby ich stosowania |
| WO2014153541A1 (en) | 2013-03-21 | 2014-09-25 | Eupraxia Pharmaceuticals USA LLC | Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith |
| RU2018119121A (ru) | 2015-10-27 | 2019-11-28 | Юпраксия Фармасьютикалз Инк. | Лекарственные формы местных анастетиков с замедленным высвобождением |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3575135D1 (de) * | 1984-09-14 | 1990-02-08 | Asta Pharma Ag | Substituierte benzylphthalazinon-derivate. |
-
1989
- 1989-04-11 MC MC892044A patent/MC2025A1/fr unknown
- 1989-04-14 EP EP89106685A patent/EP0338444B1/de not_active Expired - Lifetime
- 1989-04-14 AT AT89106685T patent/ATE97572T1/de not_active IP Right Cessation
- 1989-04-14 DE DE89106685T patent/DE58906232D1/de not_active Expired - Lifetime
- 1989-04-14 ES ES89106685T patent/ES2060685T3/es not_active Expired - Lifetime
- 1989-04-19 PT PT90308A patent/PT90308B/pt not_active IP Right Cessation
- 1989-04-19 ZA ZA892877A patent/ZA892877B/xx unknown
- 1989-04-19 HU HU891912A patent/HU202403B/hu not_active IP Right Cessation
- 1989-04-19 AU AU33183/89A patent/AU3318389A/en not_active Abandoned
- 1989-04-19 FI FI891865A patent/FI891865A7/fi not_active Application Discontinuation
- 1989-04-19 DK DK189189A patent/DK172235B1/da not_active IP Right Cessation
- 1989-04-19 IE IE126389A patent/IE62778B1/en not_active IP Right Cessation
- 1989-04-19 CA CA000597169A patent/CA1325976C/en not_active Expired - Lifetime
- 1989-04-20 JP JP1099031A patent/JP2950845B2/ja not_active Expired - Lifetime
-
1994
- 1994-12-01 HK HK134494A patent/HK134494A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2060685T3 (es) | 1994-12-01 |
| PT90308B (pt) | 1994-10-31 |
| DK172235B1 (da) | 1998-02-02 |
| ZA892877B (en) | 1989-12-27 |
| DK189189D0 (da) | 1989-04-19 |
| DK189189A (da) | 1989-10-21 |
| EP0338444B1 (de) | 1993-11-24 |
| JP2950845B2 (ja) | 1999-09-20 |
| HUT49808A (en) | 1989-11-28 |
| HU202403B (en) | 1991-03-28 |
| IE891263L (en) | 1989-10-20 |
| CA1325976C (en) | 1994-01-11 |
| EP0338444A1 (de) | 1989-10-25 |
| FI891865A0 (fi) | 1989-04-19 |
| HK134494A (en) | 1994-12-09 |
| FI891865L (fi) | 1989-10-21 |
| PT90308A (pt) | 1989-11-10 |
| DE58906232D1 (de) | 1994-01-05 |
| FI891865A7 (fi) | 1989-10-21 |
| JPH01311024A (ja) | 1989-12-15 |
| ATE97572T1 (de) | 1993-12-15 |
| IE62778B1 (en) | 1995-02-22 |
| AU3318389A (en) | 1989-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5271946A (en) | Controlled release azelastine-containing pharmaceutical compositions | |
| EP2575789B1 (fr) | Microgranules et microcomprimes resistants au detournement | |
| BE1014328A7 (fr) | Composition pharmaceutique orale a liberation controlee. | |
| EP1496869B1 (fr) | Particules enrobees a liberation prolongee et comprimes les contenant | |
| CA2283133C (fr) | Compositions pharmaceutiques pour la liberation controlee de substances actives | |
| MC2025A1 (fr) | Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee | |
| US20100047343A1 (en) | Multiparticulate formulation having tramadol in immediate and controlled release form | |
| CH669728A5 (pt) | ||
| EP0615754B1 (de) | Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe | |
| EP1492531B1 (fr) | Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiée d'amoxicilline | |
| FR2850576A1 (fr) | Composition comprenant un melange de principes actifs, et procede de preparation | |
| EP2276474A1 (fr) | Forme orale solide dotee d'un double profil de liberation comprenant des multiparticules | |
| WO1996004893A1 (fr) | Composition permettant une liberation selective d'un principe actif | |
| EP1646379A2 (fr) | Nouvelle composition pharmaceutique solide comprenant de l a misulpride | |
| JP4439499B2 (ja) | アムロジピン含有粒子およびそれからなる口腔内崩壊錠 | |
| EP1118321A1 (fr) | Compositions pharmaceutiques solides pour la libération contrôlée de substances actives | |
| CA2608185A1 (fr) | Medicament oral a base d'inhibiteur de pompe a protons | |
| JP5241681B2 (ja) | アムロジピン含有粒子およびそれからなる口腔内崩壊錠 | |
| JP2000502066A (ja) | 徐放性シサプリド | |
| WO2015198304A1 (en) | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof | |
| DE3912292A1 (de) | Azelastin enthaltende arzneimittel mit kontrollierter wirkstoffabgabe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| YP | Annual fee paid |